Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder...
SILVER SPRING, Md. /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot...
Today, the U.S. Food and Drug Administration approved Vyjuvek, a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy, for the treatment of wounds in patients 6...
FDA clears Beta Bionics iLet ACE Pump & iLet Dosing Decision Software for people with type 1 diabetes.
FDA approves first RSV vaccine, Arexvy, for those 60+ reducing risk of severe LRTD by 94.1%.
FDA supports DCTs, increasing accessibility, diversity, and efficiency in medical research.
The Centers for Disease Control and Prevention (CDC) has recently updated its guidance for the use of COVID-19 vaccines. The updated guidance includes revisions on the...
The U.S. Food and Drug Administration (FDA) has amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the...
The FDA has recently approved a cell therapy called Omisirge (omidubicel-onlv) for patients with blood cancers who are undergoing stem cell transplantation. This allogeneic cord blood-based...
Candida auris is a fungus that has caught the attention of many healthcare professionals and institutions globally. This emerging fungus poses a significant threat to public...
